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doi:10.1016/j.ejvs.2008.11.029Abstract Endovenous laser ablation (ELA) has become a standard treatment of the incompe-
tent great saphenous vein (GSV). Our prospective audit examines the implementation of this
new method in a large community hospital with special attention to obstacles, technical
results, pain scores, failures and our learning curve.
Methods: Three hundred and twenty-three patients (403 limbs) with incompetence of the GSV
underwent ELA. Patients were assessed by clinical examination and venous duplex ultrasound
was performed 6 weeks after operation. Visual analog scale (VAS) pain scores of the first post-
operative week were recorded. Operative time and success rate were analysed.
Results: After 6 weeks, 301 (74.7%) treated legs were examined by duplex ultrasound imaging.
Successful complete occlusion was present in 282 (93.7%) GSVs. Partial occlusion was present
in 12 (4.0%) GSVs. In seven (2.3%) limbs the GSV was not occluded. The maximum mean VAS
pain score was noted on the 5th postoperative day. From the start of this series, the operation
time decreased rapidly for each surgeon, stabilising after 15 limbs.
Conclusion: ELA of the incompetent GSV is effective and safe. ELA is simple to perform, well
accepted by patients and relatively atraumatic. In our opinion, ELA can be easily implemented
in surgical practice.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.)71 5262968.
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ty for Vascular Surgery. PublisheIn 2004, we decided to provide an endovenous laser abla-
tion (ELA) service for varicose veins based on published
clinical data and patients’ demand. Varicose veins are
common, arising in 20e25% of women and 10e15% of men
above the age of 15.1 Many patients are asymptomatic ord by Elsevier Ltd. All rights reserved.
Implementation of ELA for Varicose Veins 487seek treatment because of the cosmetic appearance, but
symptoms include aching, leg heaviness, pruritus and
muscle cramps and may extend to oedema, eczema, lip-
odermatosclerosis and ulceration.2,3 By far, the vast
majority (60e80%) of varicose veins arise from incompe-
tence of the saphenoefemoral junction (SFJ) and great
saphenous vein (GSV) reflux.4,5 Operations on this system
account for 80% of treatments, and 20% are for recurrent
venous reflux.6
In 1907, Babcock recommended a technique of stripping
the dilated vein7 and, currently, SFJ ligation and GSV
stripping remain the standard surgical methods. Stripping
the GSV has been shown to reduce the rate of re-operation
compared to SFJ ligation and phlebectomies only.8 Recur-
rence rates following surgery may vary from 20% to 80%,
depending on definition and timing.9e12 Surgery usually
requires general anaesthesia and is associated with signifi-
cant perioperative morbidity, cost of hospitalisation and
delayed return to normal activities and work.3,9,13,14
Minimally invasive techniques, such as ELA, have been
found to be safe and effective.15,16 Endovenous delivery of
laser energy was first reported in 1999 by Bone´,17 and this
technique allows percutaneous treatment of large-diam-
eter saphenous veins as an out-patient procedure under
local tumescent anaesthesia, with mild postoperative
symptoms.3,18e20
In our study, the immediate results of ELA for incom-




The Rijnland Hospital is a large, community training
hospital, and approximately 23 000 operations in all
specialties are performed here annually. The surgical
department consists of eight surgeons and 14 surgical
trainees. In the study period between December 2004 and
August 2007, 634 patients with symptomatic varicose veins
presented to our vascular department. Standard history
was noted and physical examinations were performed. All
patients were screened by duplex ultrasound scanning to
document patency of the deep veins and to evaluate the
competence of the superficial veins. Pre- and post-treat-
ment ultrasound investigations were performed by one of
the two specialist vascular ultrasonographers from our
radiology department using a duplex ultrasound system
with a 5e10 MHz linear probe. Reflux was assessed with the
patient in the erect position, weight bearing on the other
leg, after manual calf compression.
Venous reflux was defined as a reverse flow of more than
0.5 s. Patients with varicose veins due to SFJ and GSV reflux
were considered suitable for ELA.
Patients with a history of superficial thrombophlebitis,
aneurysmal veins larger than 2.0 cm in diameter, impal-
pable foot pulses, incompetent perforator veins or deep
venous thrombosis (DVT) and those who were pregnant,
breast-feeding or in poor general condition were not
considered suitable for ELA. After initial consultation and
evaluation, patients meeting the appropriate criteria wereoffered ELA as an alternative to surgery. Subsequently,
patients were treated according to their preference.
Bilateral treatment was permitted.
Because of the exclusion criteria described above, the
clinical, aetiological, anatomical and pathophysiological
(CEAP) classification of the treated limbs was C2e6EPASPR.
Every patient was, at least, a class 2 according to the CEAP
classification devised by the Consensus Group of the
American Venous Forum.21
Laser technique
All patients were treated with ELA under general or spinal
anaesthesia. The patient was positioned in the reverse
Trendelenburg position and skin preparation was carried
out. The GSV was cannulated near the knee under ultra-
sound guidance (Sonosite, Bothell, USA) using a 19-gauge
needle. The length of the GSV treated and the access point
were left to the discretion of the three treating surgeons
who selected the most appropriate technique. A guide-wire
was passed proximally into the femoral vein and a 5F
catheter was positioned under ultrasound imaging 2 cm
distal to the SFJ.
Peri-venous tumescent anaesthetic solution was infil-
trated along the whole length of the GSV to be ablated with
the help of ultrasound guidance. A laser fibre connected to
a 980-nm diode laser source (Biolitec AG, Jena, Germany)
was inserted via the catheter and also positioned 2 cm
distal to the SFJ. After double-checking the position with
ultrasound and the red aiming beam of light (635 nm,
4 mW), the laser fibre and catheter were then gradually
withdrawn so that the laser energy (15 W power, continuous
mode) was delivered uniformly. The pullback speed on the
fibre was calculated to achieve an energy rate of at least
50 J cm1. In the light of subsequently published data, we
increased the amount of energy delivered by laser, after 1
year, to achieve higher occlusion rates. Varices and
saphenous tributaries were treated by hook phlebectomy
(Muller’s method) with a maximum of three tiny stab
incisions.
Following treatment, a graduated compression stocking,
20e30 mmHg, was applied to the limb for 1 week. Patients
were observed for a few hours in the clinic before being
discharged with a prescription of 50 mg diclofenac sodium
tablets (to be taken thrice daily) for 7 days to reduce
inflammatory changes in the GSV and 150 mg Ranitidine to
protect the stomach. The patients were encouraged to
resume their daily activities (including work) as soon as
possible.
Postoperative evaluation
Patients returned to the clinic 1 week after treatment and
side effects or complications were recorded. We noted the
presence of ecchymosis, palpable induration, phlebitic
reaction and pain. Finally, patients were asked whether
they would undergo laser ablation again and if they would
recommend the procedure to a friend.
Duplex ultrasound assessment was repeated 6 weeks
after treatment to assess the success of saphenous abla-
tion. If GSV flow was present, venous reflux was assessed
using both Doppler waveform analysis and colour-flow
Table 1 Patient characteristics and CEAP classification of
treated leg
Characteristicsa ELA
Number of patients (n) 323
Mean age (range) 45.1 years (16e74)
Male: female 29 (9%):294 (91%)
Number of treated legs 403
C1, n (%) 0 (0)
C2, n (%) 327 (81.1)
C3, n (%) 56 (13.9)
C4, n (%) 14 (3.5)
C5, n (%) 4 (1.0)
C6, n (%) 2 (0.5)
a Categorical data are presented as n and n (%) and continuous
data as means (range)
488 J. van den Bremer et al.imaging. Veins showing flow and/or reflux in the treated
GSV were considered to be treatment failures. The deep
veins were examined for evidence of thrombosis. Three
groups of patients were identified: those with a full-length
occlusion of the treated GSV (group A); those who had
a partial occlusion of the axial vein, irrespective of the
reflux status of the SFJ (group B), and those who had no
occlusion of the axial vein (group C).
Patients with persisting significant reflux at follow-up
were offered a choice of either surgery or repeat ELA.
Assessment of pain
Pain was assessed on days 1e6 using a visual analog scale
(VAS) rating of 0 cm (no pain) to 10 cm (worst imaginable
pain). This was entered in a diary given to patients at the
completion of the procedure and reviewed at the 1-week
follow-up. The VAS took the form of 10-cm lines along
which patients were invited to make a mark corresponding
to the level of maximum pain of the affected leg.
On the same form, the patients were asked to record the
consumption of analgesics.
Learning curve
From the beginning, all procedures were performed by
three different surgeons (one vascular surgeon and two
surgical trainees). All surgeons were experienced in treat-
ing varicose veins (at least 50 operations) and were familiar
with the Seldinger technique.
In preparation for the new technique, all three had an
appropriate duplex ultrasound course lasting 2 days and,
before starting ELA in the Rijnland Hospital, the procedure
was observed 10 times in another hospital to derive expe-
rience regarding the technique.
Operative time (OR), success rate, conversion rate and
pain scores were analysed.
OR time was obtained from the anaesthetic records and
was defined as the time from the application of the anti-
septic skin preparation to the application of the compres-
sion stocking.
Data collection and analysis
Data were collected prospectively by one surgical trainee
(JvdB) and recorded on a database. The length of the vein
treated was calculated with reference to a 20-cm sterile
ruler. After each treatment, the total amount of delivered
laser energy was displayed (in joules) by the laser device.
The quotient of total laser energy in joules and the treated
vein length in centimetres was then used to calculate the
average, linear endovenous energy density (LEED),
expressed in J cm1.
Student’s t-test was used to calculate the difference in
LEED among the group with complete occlusion (group A) and
the groupwithnoocclusion (groupC).The testwas two-tailed.
The correlation between the LEED and the mean pain
score (VAS) was evaluated with Pearson’s test. The SPSS
12.0 software package (SPSS, Chicago, IL, USA) was used for
statistical analysis.
All demographic data are presented as mean -
 standard deviation and percentages unless indicated
otherwise.Results
Patients
In the study period, 634 patients with symptomatic varicose
veins presented to our vascular department. Patients with
varicose veins due to SFJ and GSV reflux were considered
suitable for ELA (474 patients, 75%).
Of the 474 patients, 140 (29.5%) were not treated by ELA
because of our exclusion criteria. Another 11 patients who
were offered ELA preferred to undergo stripping of the GSV.
ELA could not be completed in nine (2.7%) patients. In
four patients, the introducer sheath could not be passed
cranially because of a stenotic segment in the GSV above
the knee due to thrombophlebitis. In two patients, the
guide-wire would not pass into a very tortuous and enlarged
GSV. In the remaining three patients, the GSV was perfo-
rated at the access site, resulting in persistent spasm of the
vein. These procedures were then converted into high
ligation and stripping of the vein.
Of the 323 patients who eventually underwent ELA of
the GSV, 80 (24.8%) underwent bilateral treatment. Patient
demographic data and CEAP classifications are listed in
Table 1, and operative details are listed in Table 2.
Postoperative evaluation
Side effects were frequent, including haematomas and
paraesthesiae. No major complication occurred, and there
was no DVT or pulmonary embolism nor skin ulceration. All
but one patient said that they would undergo laser ablation
again and were positive in recommending the procedure to
relatives or friends. The ‘dissatisfied’ patient had
a successful ablation of the GSV, but had a severe headache
caused due to spinal anaesthetic leakage.
Duplex ultrasound
After 6 weeks, 301 (74.7%) treated legs were investigated
by duplex ultrasound imaging. Successful complete occlu-
sion was noted in 282 (93.7%) of GSVs. Partial occlusion was
present in 12 (4%), and seven saphenous veins were open
(Table 3). The LEED was similar in successfully treated and
open saphenous veins.
Table 2 Operative details
Characteristicsa ELA
Mean treated vein length,
cm (range)
38 7.3 (12e50)
Tumescent, ml 161 51 (60e350)
Total energy, J 2182 607 (612e3837)
LEED, J cm1 (range) 59 12 (39e93)
a Continuous data as means (range) and means with standard
deviation (range).
Figure 1 Mean maximum pain scores during the first seven
postoperative days. Values are mean maximum scores. The
error bars represent the 95% confidence interval.
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The diary with maximum pain scores on a VAS was returned
by 203 (62.8%) patients. Of these 203 patients, 58 had
bilateral treatment. Totally, 261 treated legs were scored.
When questioned by using a VAS pain score of 0e10 (0, no
effect; 10, worst pain ever), these patients, on average,
graded their pain at 1.64 in the first week. The maximum
day-score was noted on the 5th postoperative day (2.06).
Pain scores per day are outlined in Fig. 1. The mean VAS
scores, calculated per range of LEED, are listed in Table 4.
Slightly higher pain scores were found in patients treated
with the greatest values of LEED.
Learning curve
Of the three surgeons involved, each carried out more than
90 ELAs over the period studied. Learning curves were
created for ELA with the use of the OR time. Fig. 2 shows
the change in OR time during this series. Every period
represents five treated limbs. In the beginning, the OR time
decreased rapidly. After 15 treated limbs, the OR time
stabilised. The failures were regularly distributed over all
treatments. In the first 30 treatments, every surgeon had
one failure. The mean VAS scores in the two periods were
similar.
Discussion
ELA was introduced to reduce morbidity compared with
conventional SFJ ligation and stripping of the GSV. The
action mechanism is heating blood to produce steam,
leading to endothelial denudation, collagen contraction
and vein-wall fibrosis.22e25 The efficacy of ELA for the




Length of treated GSV, cm 37 8 (12e50)
Energy delivered, J 2125 582 (612e3837)
Energy delivered per unit
of length, J cm1
58 9 (39e93)
Continuous data presented as mean and standard deviation (range)
A Student’s t-test was used to calculate the difference in LEED among t
occlusion (group C). pZ 0.36. The test was two-tailed.extensively to be greater than 95% in obliterating the
saphenous trunk.23,26
Our complete occlusion rate is close to this reported
result. The failures were uniformly distributed over all
treatments. Therefore, we cannot blame the learning curve
for not achieving a higher success rate. Despite the lack of
an adequate clinical outcome assessment, our study
confirms that ELA is technically effective in ablating the
great saphenous vein having saphenous reflux.
For the longer term, excellent GSV occlusion rates at 5
years follow-up have been reported, manifested by clinical
improvement of symptoms.27 The frequency of successful
ablation seems greater with increasing energy density (ED,
J cm1), and a higher ED does not appear to increase the
rate of complications.28 Treatment failures were observed
in patients who received a range of LEED, including those
who received doses 70 J cm1.
Previous reports have claimed a good safety record, with
minor complications such as transient paraesthesia, skin
pigmentation or ecchymosis, induration and self-limiting
thrombophlebitis. The over all complication rate is
between 0% and 15%.14,18,29 Serious adverse events,
including arterial events, pulmonary embolism, DVT, cuta-
neous necrosis and ulceration, are rare and none occurred





39 3 (31e42) 33 8 (20e45)
2346 493 (1426e3038) 1775 461 (1181e2552)
60 9 (46e72) 54 10 (46e75)
he group with complete occlusion (group A) and the group with no











The correlation between each individual LEED value and each
mean pain score (VAS) was evaluated with Pearson’s test
(rZ 0.212).
490 J. van den Bremer et al.Few clinical studies on ELA consider post-procedural
pain. The difficulty in studying pain is the variation in pain
tolerance among patients. Pain is a common occurrence
following ELA, and resolves in most patients after a few
weeks.30,31 The pain after ELA does not seem to be corre-
lated to the laser energy deposition.31 Postoperative pain in
the treated leg was found frequently in our series, but the
pain scores were low. The pain noted after the procedure
was primarily located in the thigh and may have been
related to superficial phlebitis, rather than to the ecchy-
mosis. Compared to our previous surgical methods, we did
not encounter greater pain scores following the introduc-
tion of ELA.
We experienced great patient satisfaction from the
beginning. The number of patients with symptomatic vari-
cose veins attending our vascular department increased
rapidly after the (locally published) introduction of ELA in
our clinic. The numbers increased by 31% and the increase
is still in force. All but one responded that they would
undergo laser ablation again and were positive in recom-
mending the procedure to relatives or friends. The only
patient who was not satisfied had reasons not directly
related to the ELA.
The introduction of new techniques has brought interest
in the learning curve experienced by surgeons adopting





































Figure 2 The mean operation time of each individual
surgeon expressed for each consecutive period (a period
corresponds with five procedures)at the correct place in the vein but is otherwise technically
easy.
The average OR time was 29 min to perform, but at the
beginning the OR time was between 50 and 60 min. This
decreased rapidly with increasing experience so that, after
15 cases, a level equal to the mean OR time of the last 300
procedureswas attained.As a consequence, the introduction
of ELA in our hospital had veryminimal effects on ourOR time
schedule.
Conclusion
ELA of the incompetent GSV with a 980-nm diode laser
appears to be effective and safe. ELA is simple to perform,
well accepted by patients and relatively atraumatic. In our
opinion, ELA can be easily implemented in surgical practice
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